:format(jpg):watermark(cloudfront-eu-central-1.images.arcpublishing.com/ipmgroup/EF665FJJCNGHFFHRRMWR57UKMI.png,0,30,0)/cloudfront-eu-central-1.images.arcpublishing.com/ipmgroup/EVS7PXV6PJETFLBIQ2IWGXHA6A.jpg "Year of “exceptional performance” for the Belgian company IBA")
The neo-Luvanist company IBA reported on Tuesday its “outstanding performancein 2021 and a record backlog, according to an interim statement. In 2021, the world leader in particle acceleration technology sold five systems (nine rooms) of proton therapy, compared to two systems sold the previous year , and more than 30″other accelerators“, against 17 the previous year.
What to achieve a turnover “in line with the previous year“, with a positive operating result and net profit at group level and profitability in all business areas. In 2020, IBA had recorded a turnover of 312 million euros.
Historical record for the order book: 1.2 billion euros
IBA adds that it has an order book that reached a new all-time high of 1.2 billion euros and benefited from a net cash position, also record, of 130.3 million euros at the end of 2021.
“IBA achieved an exceptional performance in 2021, with a high level of order intake and demonstrated profitability in all business sectors“Summarizes CEO Olivier Legrain.
IBA will publish its annual results on Thursday March 24 (before market).
–
